Intermune’s Esbriet Flops In Front Of IQWiG
This article was originally published in The Pink Sheet Daily
Executive Summary
Germany’s IQWiG remains unconvinced about the added value offered by Intermune’s Esbriet, a decision that adds to industry concerns on assessment methodology